Nanox Release Technology S.A. is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about Nanox Release Technology S.A.. ONE STOP SOLUTION FOR DRUG DELIVERY Nanox focuses on the development of pharmaceutical products with complex drug delivery technologies like liposomes, pegylated liposomes, and microspheres depot with PLGA (polylactide - polyglycolide copolymers) formulations. Nanox owns worldwide rights for GM1-Nanomicelles, an innovative carrier for oncological drugs in preclinical stage currently being tested in neuro-oncology indications due its unique capacity to pass the Blood-Brain barrier
Address
Le Corbusier 1562
Company size
11-50 employees
Headquarters
El Triángulo, Buenos Aires